SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001511164-17-000694
Filing Date
2017-11-15
Accepted
2017-11-15 12:24:02
Documents
1
Period of Report
2017-09-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2105
  Complete submission text file 0001511164-17-000694.txt   3721
Mailing Address 1801 CENTURY PARK EAST 24TH FLOOR LOS ANGELES CA 90067
Business Address 1801 CENTURY PARK EAST 24TH FLOOR LOS ANGELES CA 90067 866-443-4666
Hoverink Biotechnologies, Inc. (Issuer) CIK: 0001586494 (see all company filings)

IRS No.: 463590875 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10250 CONSTELLATION BLVD SUITE 2300 CENTURY CITY CA 90067
Business Address
Sajna Cyrus (Reporting) CIK: 0001653740 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55055 | Film No.: 171204546